Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04574895 · ClinicalTrials.gov registry record · NA
Using a Real-Time Risk Prediction Model to Predict Pediatric Venous Thromboembolism (VTE) Events
A NA study of Pulmonary Embolism and Venous Thromboembolism, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 17,427
- Enrollment target
- 1
- Study location
NCT04574895 is a NA study of Pulmonary Embolism and Venous Thromboembolism that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 17,427 participants, above the 2,695-participant average among 48 other Pulmonary Embolism trials with a reported enrollment target (547% higher). The trial reports 1 study location across 1 state.
The verdict
NCT04574895, a NA study of Pulmonary Embolism and Venous Thromboembolism, has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 17,427 participants
- Enrollment target
- 1
- Study location
Study Summary
The study will evaluate the effectiveness of a novel, real-time risk prediction model for identifying pediatric patients at risk for developing in-hospital blood clots (or venous thromboembolism \[VTE\]) based on data easily extracted from the electronic medical record. The study will assess whether using the risk percentages for developing VTE derived from the model increases the number of high-risk patients screened by the pediatric hematology team, which may may lead to an overall reduction in the number of pediatric VTEs seen at Monroe Carell Jr. Children's Hospital at Vanderbilt.
Conditions Studied
Interventions
- OTHER Hematology Review
Study Locations (1)
Tennessee
- Vanderbilt University Medical Center - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17,427 participants |
| Start Date | 2020-11-02 |
| Est. Completion | 2023-12-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04574895
The ClinicalTrials.gov registry entry for NCT04574895 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 17,427 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 2,695-participant average among 48 other Pulmonary Embolism trials with a reported enrollment target (547% higher). The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Pulmonary Embolism appearing as the primary indexed condition, and to 1 intervention - of which Hematology Review is the first listed.
NCT04574895 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.
Frequently Asked Questions
What is clinical trial NCT04574895 about?
NCT04574895 is a clinical study titled "Using a Real-Time Risk Prediction Model to Predict Pediatric Venous Thromboembolism (VTE) Events". The study will evaluate the effectiveness of a novel, real-time risk prediction model for identifying pediatric patients at risk for developing in-hospital blood clots (or venous thromboembolism \[VTE\]) based on data easily extracted from the electronic medical record. The study will assess whether...
What is the current status of trial NCT04574895?
This trial is currently completed. It is a NA study. The enrollment target is 17,427 participants. The study started on 2020-11-02. Estimated completion is 2023-12-01.
What conditions does trial NCT04574895 study?
This clinical trial studies the following conditions: Pulmonary Embolism, Venous Thromboembolism, Deep Vein Thrombosis, Pediatrics.
What interventions are being tested in trial NCT04574895?
The interventions under investigation include: Hematology Review (OTHER).
Who is sponsoring clinical trial NCT04574895?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04574895 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pulmonary Embolism
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study of Mobility Outcomes in Post-Pulmonary Embolic Disease
RECRUITING · NA
-
Intervention to Improve Utilization of Extended Venous Thromboembolism Prophylaxis After Cancer Surgery
RECRUITING · NA
-
Clinical Utility of Portable Dynamic Chest X Ray (DDR) in the ICU
RECRUITING · NA
-
The PERSEVERE Study
RECRUITING · NA
-
The PEERLESS II Study
RECRUITING · NA
-
Treating Pulmonary Embolism With Laguna Thrombectomy System (TRUST)
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.